Varenyam Biolifesciences Raises Phase 1 Capex to ₹300 Crore for CDMO Facility
MM Desk
22 August, 2026
Varenyam Biolifesciences, a wholly owned subsidiary of Bharat Parenterals Limited, has decided to upgrade its